Oncology Drugs Experience Sales Slowdown In U.S.
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
NuVue Therapeutics is commercializing a site-specific regimen of cancer therapy for soft tissue tumors.
Copyright © 2024 | WordPress Theme by MH Themes